I thought the call was very positive regarding the science, yet absolute dog food regarding the stock and business side of things.
Some will sell tomorrow. Not smart IMO, especially if you want uplisting to happen. If we do drop below $3, heaven forbid, I’ll only be pissed bc it means I gotta scrape more money together and buy.
I also found Nader’s comment about “blinking” and the whole discussion of IMMU rather interesting. The optimist in me thinks that might of been one of his clues, think of it as Nader sipping from a Pfizer mug.
The EIND anecdotes were great. They bode well for S/C results.
Also, f*** the FDA. If they demand we finish trial when interim results are great then take that “f*** the FDA” and times it by 1000.